Management of hepatocellular carcinoma in elderly and adolescent/young adult populations [0.03%]
老年和青少年丙型肝炎肝癌的治疗研究
Han Ah Lee
Han Ah Lee
Hepatocellular carcinoma (HCC) presents unique challenges in both the elderly and adolescent/young adult (AYA) populations, requiring distinct management approaches. Recent epidemiological data show an increasing incidence of HCC in both ag...
Insights into hepatocellular adenomas in Asia: molecular subtypes, clinical characteristics, imaging features, and hepatocellular carcinoma risks [0.03%]
亚洲肝细胞腺瘤的见解：分子亚型、临床特征、影像学特征和肝细胞癌风险
Subin Heo,In Hye Song,Edouard Reizine et al.
Subin Heo et al.
Hepatocellular adenomas (HCAs) are benign monoclonal liver tumors. Advances in molecular studies have led to the identification of distinct subtypes of HCA with unique pathways, clinical characteristics, and complication risks, underscoring...
Epidemiology and genomic features of biliary tract cancer and its unique features in Korea [0.03%]
胆道癌症的流行病学及其基因特征和在韩国的独特特征
Seonjeong Woo,Youngun Kim,Sohyun Hwang et al.
Seonjeong Woo et al.
Biliary tract cancer (BTC) is a rare but highly aggressive malignancy that includes intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma (ECC), and gallbladder cancer (GBC). While BTC has a low global incidence, its region...
Hepatocellular Carcinoma in Korea: An Analysis of the 2016-2018 Korean Nationwide Cancer Registry [0.03%]
韩国的肝细胞癌：对2016-2018年韩国全国癌症登记的分析
Jihyun An,Young Chang,Gwang Hyeon Choi et al.
Jihyun An et al.
Background/aims: Hepatocellular carcinoma (HCC) is the sixth most common cancer and second leading cause of cancer-related deaths in South Korea. This study evaluated the characteristics of Korean patients newly diagnosed...
Recent Advances and Issues in Imaging Modalities for Hepatocellular Carcinoma Surveillance [0.03%]
肝细胞癌筛查成像技术的新进展和问题
Dong Ho Lee
Dong Ho Lee
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. Early detection via surveillance plays a crucial role in enabling curative treatment and improving survival rates. Since the initial randomized control...
A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024 [0.03%]
2017-2024年全球肝细胞癌管理指南更新简述
Hyunjae Shin,Su Jong Yu
Hyunjae Shin
Many guidelines for hepatocellular carcinoma (HCC) have been published and are regularly updated worldwide. HCC management involves a broad range of treatment options and requires multidisciplinary care, resulting in significant heterogenei...
Enhanced Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma Post-Transarterial Chemoembolization: A Prospective Study Utilizing Twin Internally Cooled-Perfusion Electrodes [0.03%]
经导管动脉化疗栓塞术后复发性肝细胞癌的射频消融：一项利用双内冷灌注电极增强射频消融的前瞻性研究
Sungjun Hwang,Jae Hyun Kim,Sae-Jin Park et al.
Sungjun Hwang et al.
Background: Radiofrequency ablation (RFA) is widely employed for managing recurrent hepatocellular carcinoma (HCC) following transarterial chemoembolization (TACE). However, local tumor progression (LTP) after treatment r...
Microwave ablation versus liver resection for patients with hepatocellular carcinomas [0.03%]
微波消融与肝脏切除治疗肝细胞癌患者的疗效比较
Hyundam Gu,Yeonjoo Seo,Dong Jin Chung et al.
Hyundam Gu et al.
Backgrounds/aims: Microwave ablation (MWA) is an emerging ablative therapy that surpasses previous methods by achieving higher temperatures and creating larger ablation zones within shorter periods. This study compared th...